3o1g
From Proteopedia
(Difference between revisions)
m (Protected "3o1g" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3o1g.png|left|200px]] | [[Image:3o1g.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3o1g", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3o1g| PDB=3o1g | SCENE= }} | {{STRUCTURE_3o1g| PDB=3o1g | SCENE= }} | ||
===Cathepsin K covalently bound to a 2-cyano pyrimidine inhibitor with a benzyl P3 group.=== | ===Cathepsin K covalently bound to a 2-cyano pyrimidine inhibitor with a benzyl P3 group.=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_20843687}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 20843687 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_20843687}} | {{ABSTRACT_PUBMED_20843687}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
| - | *[[Cathepsin]] | + | *[[Cathepsin|Cathepsin]] |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:020843687</ref><references group="xtra"/> |
[[Category: Cathepsin K]] | [[Category: Cathepsin K]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
Revision as of 06:53, 27 July 2012
Contents |
Cathepsin K covalently bound to a 2-cyano pyrimidine inhibitor with a benzyl P3 group.
Template:ABSTRACT PUBMED 20843687
About this Structure
3o1g is a 1 chain structure of Cathepsin with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Rankovic Z, Cai J, Kerr J, Fradera X, Robinson J, Mistry A, Finlay W, McGarry G, Andrews F, Caulfield W, Cumming I, Dempster M, Waller J, Arbuckle W, Anderson M, Martin I, Mitchell A, Long C, Baugh M, Westwood P, Kinghorn E, Jones P, Uitdehaag JC, van Zeeland M, Potin D, Saniere L, Fouquet A, Chevallier F, Deronzier H, Dorleans C, Nicolai E. Optimisation of 2-cyano-pyrimidine inhibitors of cathepsin K: Improving selectivity over hERG. Bioorg Med Chem Lett. 2010 Aug 24. PMID:20843687 doi:10.1016/j.bmcl.2010.08.101
